Amgen to pay Mass. General $186m
Lump sum payment will end dispute over arthritis drug royalty
Amgen Inc. has agreed to pay Massachusetts General Hospital $186 million to settle a royalty dispute over Enbrel, a lucrative drug used to treat rheumatoid arthritis, hospital officials said yesterday. (Full article: 635 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
